Xilio Therapeutics

Developer of immunotherapies for the treatment of cancer

placeWaltham, Massachusetts, United States calendar_todayFounded 2016 groups72 employees language xiliotx.com

Registered entities

Social engagement

Social engagement: 11.3K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include Takeda Ventures, F-Prime Capital, Atlas Venture, Rock Springs Capital; 1 has since exited.

Investor typeCountShare
Venture capital1372%
Bank & private debt16%
Other / undisclosed422%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

28 Jul 2025 · Bioinformatics Data Scientist · Waltham

Based on job postings tracked across public sources.

Recent activity

17 Apr 2026
Event
AACR26 Annual Meeting for XTX601
Coming soon